Novavax, Inc. (NVAX)
10.09
-0.55
(-5.17%)
USD |
NASDAQ |
Mar 18, 15:51
Novavax Total Assets (Quarterly) : 1.183B for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Pfizer Inc. | 208.16B |
| Moderna, Inc. | 12.34B |
| Merck & Co., Inc. | 136.87B |
| Intellia Therapeutics, Inc. | 842.13M |
| Recursion Pharmaceuticals, Inc. | 1.528B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 1.311B |
| Shareholders Equity (Quarterly) | -127.75M |
| Debt to Equity Ratio | -2.176 |
| Current Ratio | 2.127 |
| Net Debt Paydown Yield | -0.82% |